| http://purl.uniprot.org/citations/35874783 | http://www.w3.org/1999/02/22-rdf-syntax-ns#type | http://purl.uniprot.org/core/Journal_Citation |
| http://purl.uniprot.org/citations/35874783 | http://www.w3.org/2000/01/rdf-schema#comment | "Surfactant protein D (SP-D), a pattern recognition molecule, is emerging as a potent anti-tumoural innate immune defense molecule in a range of cancers. Previously, SP-D expression was found to be significantly downregulated at the malignant sites of human prostate adenocarcinoma and associated with an increasing Gleason score and severity. We recently reported selective induction of intrinsic apoptosis by a recombinant fragment of human SP-D (rfhSP-D) in the human Prostate cancer (PCa) biopsy explants and cells with glucose regulated protein of 78 (GRP78) as one of the key interacting partners. The present study evaluated the expression of SP-D in early and advanced stages of PCa using transgenic adenocarcinoma of mouse prostate (TRAMP) model. Both early and late stages of PCa showed significantly decreased SP-D mRNA expression and increased proteolytic degradation of SP-D protein. Systemic and tumoural immunophenotyping of TRAMP model revealed increased serine proteases producing granulocytes and polymorphonuclear myeloid-derived suppressor cells (PMN MDSCs) in the late stage; the serine proteases secreted by these cells could be involved in the degradation of SP-D. Susceptibility of rfhSP-D to elastase-mediated proteolysis provided the rationale to use an elastase-inhibitor to sustain intact rfhSP-D in the tumour microenvironment. The study revealed an immunomodulatory potential of rfhSP-D and elastase inhibitor, sivelestat, to induce macrophage polarization towards M1 with downregulation of PMN MDSCs in ex-vivo cultured TRAMP tumours. Furthermore, rfhSP-D induced immunogenic cell death in murine PCa cells and in TRAMP explants. The findings highlight that SP-D plays an anti-tumourigenic role in PCa by inducing immunogenic cell death and immunomodulation while the prostate tumour milieu adversely impacts SP-D by inhibiting its transcription, and enhancing its proteolytic degradation. Transformation of an immunologically "cold tumour" into a "hot tumour" implicates therapeutic potential of rfhSP-D in PCa."xsd:string |
| http://purl.uniprot.org/citations/35874783 | http://purl.org/dc/terms/identifier | "doi:10.3389/fimmu.2022.930449"xsd:string |
| http://purl.uniprot.org/citations/35874783 | http://purl.uniprot.org/core/author | "Madan T."xsd:string |
| http://purl.uniprot.org/citations/35874783 | http://purl.uniprot.org/core/author | "Ganguly K."xsd:string |
| http://purl.uniprot.org/citations/35874783 | http://purl.uniprot.org/core/author | "Kishore U."xsd:string |
| http://purl.uniprot.org/citations/35874783 | http://purl.uniprot.org/core/author | "Metkari S.M."xsd:string |
| http://purl.uniprot.org/citations/35874783 | http://purl.uniprot.org/core/date | "2022"xsd:gYear |
| http://purl.uniprot.org/citations/35874783 | http://purl.uniprot.org/core/name | "Front Immunol"xsd:string |
| http://purl.uniprot.org/citations/35874783 | http://purl.uniprot.org/core/pages | "930449"xsd:string |
| http://purl.uniprot.org/citations/35874783 | http://purl.uniprot.org/core/title | "Immunomodulatory Role of Surfactant Protein-D in a Transgenic Adenocarcinoma of Mouse Prostate (TRAMP) Model."xsd:string |
| http://purl.uniprot.org/citations/35874783 | http://purl.uniprot.org/core/volume | "13"xsd:string |
| http://purl.uniprot.org/citations/35874783 | http://www.w3.org/2004/02/skos/core#exactMatch | http://purl.uniprot.org/pubmed/35874783 |
| http://purl.uniprot.org/citations/35874783 | http://xmlns.com/foaf/0.1/primaryTopicOf | https://pubmed.ncbi.nlm.nih.gov/35874783 |
| http://purl.uniprot.org/uniprot/#_P50404-mappedCitation-35874783 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/35874783 |
| http://purl.uniprot.org/uniprot/P50404 | http://purl.uniprot.org/core/mappedCitation | http://purl.uniprot.org/citations/35874783 |